abstract |
FIELD: medicine. n SUBSTANCE: there is described a new compound - 1-(β-phenylethyl)-4-amino-1,2,4-triazolium bromide exhibiting cardioprotective, anti-ischemic, antihypertensive, antioxidant, protein synthetic and energotropic action. n EFFECT: improved clinical effectiveness. n 1 cl, 5 ex, 4 tbl |